Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: Results of a double-blind, randomised placebo-controlled trial

Annals of the Rheumatic Diseases

Volumn 72, Issue 6, 2013, Pages

  Murphy, Claire Louise ^a   Murphy, Eithne ^a   Duffy, Trevor ^a   O'Sullivan, Miriam ^a   Barry, Maurice ^a  

^a Royal College of Surgeons in Ireland   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; STRONTIUM RANELATE;

BODY MASS; DRUG EFFICACY; DRUG SAFETY; EXERCISE; HUMAN; KNEE OSTEOARTHRITIS; LETTER; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); WEIGHT CHANGE; WEIGHT REDUCTION;

ADULT ONSET STILL'S DISEASE; AMYLOIDOSIS; ANALGESICS;

ANTIRHEUMATIC AGENTS; FEMALE; HUMANS; MALE; ORGANOMETALLIC COMPOUNDS; OSTEOARTHRITIS, KNEE; THIOPHENES;

EID: 84877593433     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203637     Document Type: Letter

References (3)

1. Reginster JY, Badurski J, Bellamy N, et al. Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial. Ann Rheum Dis 2013;72:179-86.
2. Cooper C, Snow S, McAlindon TE, et al. Risk factors for the incidence and progression of radiographic knee osteoarthritis. Arthritis Rheum 2000;43:995-1000. (Pubitemid 30368175)
3. Coggon D, Reading I, Croft P, et al. Knee Osteoarthritis and Obesity. Int J Obes 2001;25:622-7. (Pubitemid 32417630)